Also, Dong et al., [34] found that EGFR wild-type NSCLC tumors were more likely to be PD-L1 positive then EGFR mutant tumors (OR 1.79, 95% C.I. 1.10–2.93; p = 0.02). This evidence concerns the gene EGFR and non-small cell lung carcinoma.